So much more than Aspirin…a study visit at Bayer

Discussions are intense as Ben Armstrong, Jennifer Bold and Alan Meyer from Drug Discovery and Preclinical Development at Ygeia, a US based pharma company focusing on oncology, are discussing the potential in four different drug candidates. Their patent is running out and they have new compounds in different stages to work with but budgets are… Read More So much more than Aspirin…a study visit at Bayer